SLC27A4 and neoplasm: In agreement with the in vitro model, subcutaneous injection of PLC/PRF/5 SLC27A4‐KD cells into mice resulted in significantly slower tumour growth and reduced responsiveness to sEV from metastatic cells compared to CTL‐KD cells (Figure 6e,f).